673 followers
Why aren't CTCs eval standard of care yet for #breastcancer mets? http://t.co/7S2Bkm6tyL #oncology #dontignorestage4
Why aren't CTCs eval standard of care yet for #breastcancer mets? http://t.co/7S2Bkm6tyL #oncology #dontignorestage4
RT @SymPathoBiology: Circulating tumor cells in HER2-positive metastatic breast cancer patients. #mdart #md http://t.co/yzu9hYuTWX
Circulating tumor cells in HER2-positive metastatic breast cancer patients. #mdart #md http://t.co/Yp6kP1LEo2
Circulating tumor cells in HER2-positive metastatic breast cancer patients. #mdart #md http://t.co/yzu9hYuTWX